Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
33733 | 121 | 31.7 | 63% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
3 | 4 | PLANT SCIENCES//AGRONOMY//FOOD SCIENCE & TECHNOLOGY | 1882812 |
2 | 3 | INTEGRATIVE & COMPLEMENTARY MEDICINE//CHEMISTRY, MEDICINAL//ESSENTIAL OIL | 193989 |
2181 | 2 | TANSHINONE IIA//SALVIA MILTIORRHIZA//SALVIANOLIC ACID B | 4938 |
33733 | 1 | NEUROAID//MLC601//MLC901 | 121 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | NEUROAID | authKW | 4555100 | 16% | 95% | 19 |
2 | MLC601 | authKW | 2294182 | 8% | 91% | 10 |
3 | MLC901 | authKW | 1009441 | 3% | 100% | 4 |
4 | DANZHIJIANGTANG CAPSULE | authKW | 504720 | 2% | 100% | 2 |
5 | DAVAO MED FDN HOSP | address | 504720 | 2% | 100% | 2 |
6 | XINMAILONG | authKW | 504720 | 2% | 100% | 2 |
7 | RAFFLES NEUROSCI | address | 267195 | 5% | 18% | 6 |
8 | ACTIVATE BLOOD CIRCULATION | authKW | 252360 | 1% | 100% | 1 |
9 | AMI CHINESE MEDGUANGDONG PROV CHINE | address | 252360 | 1% | 100% | 1 |
10 | ANTI VCA IGG ANTIBODY | authKW | 252360 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Integrative & Complementary Medicine | 2453 | 17% | 0% | 21 |
2 | Peripheral Vascular Diseases | 731 | 23% | 0% | 28 |
3 | Clinical Neurology | 135 | 16% | 0% | 19 |
4 | Tropical Medicine | 123 | 5% | 0% | 6 |
5 | Social Sciences, Biomedical | 37 | 2% | 0% | 3 |
6 | Medicine, General & Internal | 32 | 9% | 0% | 11 |
7 | Endocrinology & Metabolism | 24 | 7% | 0% | 8 |
8 | Pediatrics | 16 | 5% | 0% | 6 |
9 | Cardiac & Cardiovascular System | 16 | 6% | 0% | 7 |
10 | Medicine, Research & Experimental | 12 | 5% | 0% | 6 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DAVAO MED FDN HOSP | 504720 | 2% | 100% | 2 |
2 | RAFFLES NEUROSCI | 267195 | 5% | 18% | 6 |
3 | AMI CHINESE MEDGUANGDONG PROV CHINE | 252360 | 1% | 100% | 1 |
4 | CENT QUEENSLAND | 252360 | 1% | 100% | 1 |
5 | FICTICIOUS ECON DATA SCI | 252360 | 1% | 100% | 1 |
6 | GENET TCM | 252360 | 1% | 100% | 1 |
7 | MED INFORMAT BIOMETTY EPIDEMIOL IBE | 252360 | 1% | 100% | 1 |
8 | METAB ENDOCRINOLMINIST EDUCXIANGYA HOSP | 252360 | 1% | 100% | 1 |
9 | NEUROL INTEGRATED TRADIT CHINESE WESTERN M | 252360 | 1% | 100% | 1 |
10 | SAN VICENTE WARD | 252360 | 1% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CEREBROVASCULAR DISEASES | 12183 | 10% | 0% | 12 |
2 | INTERNATIONAL JOURNAL OF STROKE | 11853 | 6% | 1% | 7 |
3 | JOURNAL OF TRADITIONAL CHINESE MEDICINE | 8425 | 4% | 1% | 5 |
4 | CHINESE JOURNAL OF INTEGRATIVE MEDICINE | 3924 | 3% | 0% | 4 |
5 | BACH | 3503 | 1% | 1% | 1 |
6 | ANAESTHESIA CRITICAL CARE & PAIN MEDICINE | 2654 | 1% | 1% | 1 |
7 | EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE | 2251 | 6% | 0% | 7 |
8 | JOURNAL OF TROPICAL PEDIATRICS | 1520 | 3% | 0% | 4 |
9 | BMC CARDIOVASCULAR DISORDERS | 846 | 2% | 0% | 2 |
10 | ANNALS OF TROPICAL PAEDIATRICS | 728 | 2% | 0% | 2 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NEUROAID | 4555100 | 16% | 95% | 19 | Search NEUROAID | Search NEUROAID |
2 | MLC601 | 2294182 | 8% | 91% | 10 | Search MLC601 | Search MLC601 |
3 | MLC901 | 1009441 | 3% | 100% | 4 | Search MLC901 | Search MLC901 |
4 | DANZHIJIANGTANG CAPSULE | 504720 | 2% | 100% | 2 | Search DANZHIJIANGTANG+CAPSULE | Search DANZHIJIANGTANG+CAPSULE |
5 | XINMAILONG | 504720 | 2% | 100% | 2 | Search XINMAILONG | Search XINMAILONG |
6 | ACTIVATE BLOOD CIRCULATION | 252360 | 1% | 100% | 1 | Search ACTIVATE+BLOOD+CIRCULATION | Search ACTIVATE+BLOOD+CIRCULATION |
7 | ANTI VCA IGG ANTIBODY | 252360 | 1% | 100% | 1 | Search ANTI+VCA+IGG+ANTIBODY | Search ANTI+VCA+IGG+ANTIBODY |
8 | CAL ALPHA 1C | 252360 | 1% | 100% | 1 | Search CAL+ALPHA+1C | Search CAL+ALPHA+1C |
9 | CENTRAL ACEH | 252360 | 1% | 100% | 1 | Search CENTRAL+ACEH | Search CENTRAL+ACEH |
10 | CHINESE MEDICINE SAFETY | 252360 | 1% | 100% | 1 | Search CHINESE+MEDICINE+SAFETY | Search CHINESE+MEDICINE+SAFETY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | VENKETASUBRAMANIAN, N , KUMAR, R , SOERTIDEWI, L , ABU BAKAR, A , LAIK, C , GAN, R , (2015) THE NEUROAID SAFE TREATMENT (NEST) REGISTRY: A PROTOCOL.BMJ OPEN. VOL. 5. ISSUE 11. P. - | 23 | 72% | 0 |
2 | VENKETASUBRAMANIAN, N , YOUNG, SH , TAY, SS , UMAPATHI, T , LAO, AY , GAN, HH , BAROQUE, AC , NAVARRO, JC , CHANG, HM , ADVINCULA, JM , ET AL (2015) CHINESE MEDICINE NEUROAID EFFICACY ON STROKE RECOVERY - EXTENSION STUDY (CHIMES-E): A MULTICENTER STUDY OF LONG-TERM EFFICACY.CEREBROVASCULAR DISEASES. VOL. 39. ISSUE 5-6. P. 309 -318 | 17 | 41% | 6 |
3 | CHEN, CLH , YOUNG, SHY , GAN, HH , SINGH, R , LAO, AY , BAROQUE, AC , CHANG, HM , HIYADAN, JHB , CHUA, CL , ADVINCULA, JM , ET AL (2013) CHINESE MEDICINE NEUROAID EFFICACY ON STROKE RECOVERY A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY.STROKE. VOL. 44. ISSUE 8. P. 2093-2100 | 14 | 52% | 18 |
4 | SHAHRIPOUR, RB , HEMATI, A , MALEKI, AH , (2014) A RANDOMIZED TRIAL TO ASSESS THE LONG-TERM SAFETY OF NEUROAID AMONG CAUCASIAN PATIENTS WITH ACUTE ISCHEMIC STROKE.CHINESE JOURNAL OF INTEGRATIVE MEDICINE. VOL. 20. ISSUE 11. P. 812 -817 | 7 | 100% | 2 |
5 | GONZALEZ-FRAILE, E , MARTIN-CARRASCO, M , BALLESTEROS, J , (2016) EFFICACY OF MLC601 ON FUNCTIONAL RECOVERY AFTER STROKE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS.BRAIN INJURY. VOL. 30. ISSUE 3. P. 267 -270 | 8 | 73% | 0 |
6 | NAVARRO, JC , CHEN, CLH , LAGAMAYO, PDJ , GESLANI, MB , EOW, GB , POUNGVARIN, N , DE SILVA, A , WONG, LKS , VENKETASUBRAMANIAN, N , (2013) CHIMES-I: SUB-GROUP ANALYZES OF THE EFFECTS OF NEUROAID ACCORDING TO BASELINE BRAIN IMAGING CHARACTERISTICS AMONG PATIENTS RANDOMIZED IN THE CHIMES STUDY.INTERNATIONAL JOURNAL OF STROKE. VOL. 8. ISSUE 6. P. 491-494 | 9 | 64% | 2 |
7 | SIDDIQUI, FJ , VENKETASUBRAMANIAN, N , CHAN, ESY , CHEN, C , (2013) EFFICACY AND SAFETY OF MLC601 (NEUROAID (R)), A TRADITIONAL CHINESE MEDICINE, IN POSTSTROKE RECOVERY: A SYSTEMATIC REVIEW.CEREBROVASCULAR DISEASES. VOL. 35. ISSUE . P. 8-17 | 8 | 67% | 7 |
8 | GANDIN, C , WIDMANN, C , LAZDUNSKI, M , HEURTEAUX, C , (2016) MLC901 FAVORS ANGIOGENESIS AND ASSOCIATED RECOVERY AFTER ISCHEMIC STROKE IN MICE.CEREBROVASCULAR DISEASES. VOL. 42. ISSUE 1-2. P. 139 -154 | 16 | 30% | 0 |
9 | LI, JS , ZHENG, HZ , ZHAO, XF , WANG, S , SHI, XM , (2013) SAFETY AND EFFICACY OF DANQIPIANTAN CAPSULE FOR TREATMENT OF STROKE: A SYSTEMATIC REVIEW.JOURNAL OF TRADITIONAL CHINESE MEDICINE. VOL. 33. ISSUE 6. P. 707-714 | 8 | 62% | 1 |
10 | VENKETASUBRAMANIAN, N , YOUNG, S , TAY, SS , CHANG, HM , UMAPATHI, T , CHAN, B , DE SILVA, A , WONG, L , NAVARRO, J , ZHAO, YD , ET AL (2013) CHINESE MEDICINE NEUROAID EFFICACY STROKE RECOVERY - EXTENSION STUDY (CHIMES-E STUDY): AN OBSERVATIONAL MULTICENTER STUDY TO INVESTIGATE THE LONGER-TERM EFFICACY OF NEUROAID IN STROKE RECOVERY.CEREBROVASCULAR DISEASES. VOL. 35. ISSUE . P. 18-22 | 10 | 40% | 4 |
Classes with closest relation at Level 1 |